Children to be seen (and heard) at EMA paediatric committee
This article was originally published in Scrip
Executive Summary
The European Medicines Agency is planning to allow children to participate in its paediatrics committee (PDCO) meetings to get their feedback on a range of issues affecting the development of children's medicines, such as trial designs and selection of endpoints.